The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Evaluation of cost-effectiveness of early KRAS testing in high-risk recurrence colorectal cancer patients in Italy.
Carmine Pinto
No relevant relationships to disclose
Carlo Barone
No relevant relationships to disclose
Nicola Normanno
No relevant relationships to disclose
Francesco Cognetti
No relevant relationships to disclose
Alfredo Falcone
No relevant relationships to disclose
Lorenzo Capussotti
No relevant relationships to disclose
Lorenzo Mantovani
No relevant relationships to disclose